Search - tctmd.com

Displaying 541 - 560 of 8351

Sort: Relevancy | Date

Presentation TCT 2016

Acute MI/SVGS/Thrombus Containing Lesions: Mesh-Covered Mguard Prime

Presenter: Chaim S. Lotan, Giora Weisz

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

Presentation TCT 2016

A Prospective, Randomized Trial of Impella vs Intra-aortic Balloon Counterpulsation in Patients with Cardiogenic Shock

Presenter: Thomas F. Luscher, Patrick W. Serruys, Jose P.S. Henriques

October 31, 2016

Presentation TCT 2016

Small Vessels: Svelte Stent On A Wire

Presenter: Chaim S. Lotan, Giora Weisz, Jordan Safirstein

October 31, 2016

Presentation TCT 2016

Colombia Presents : A Case of Aorto-Cameral Fistula Management: How Did I Treat?

Presenter: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari

October 31, 2016

Presentation TCT 2016

TCT 94: Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study

Presenter: Farouc Jaffer, Amir Lerman, Elvin Kedhi

October 31, 2016

Presentation TCT 2016

TCT 70: Final 5 Year Results from the COMPARE II Trial: Comparison Between the Durable Polymer Coated Everolimus-Eluting Xience/Promus Stent and the Biodegradable Polymer Coated Biolimus-Eluting Nobori Stent in All-Comer Population

Presenter: Giuseppe De Luca, Christoph A. Kaiser, Pieter C. Smits

October 31, 2016

Presentation TCT 2016

TCT 65: Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A Pooled Patient Level Analysis From 17 Randomized Trials

Presenter: Sorin J. Brener, Jean-François Tanguay, Jaya Chandrasekhar

October 31, 2016

Presentation TCT 2016

TCT 62: Outcomes of Reattempt Percutaneous Coronary Intervention for Chronic Total Occlusion: Two-year Data From Retrograde Summit Registry

Presenter: Julinda Mehilli, Georgios Sianos, Shozo Ishihara

October 31, 2016

Presentation TCT 2016

TCT 58: Long-term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Scaffolds During Daily Practice Two-Year Results From the ISAR-ABSORB Registry

Presenter: Antonio L. Bartorelli, Kenneth Chin, Jens Wiebe

October 31, 2016

Presentation TCT 2016

TCT 54: LEADERS FREE OAC: Biolimus A9 Coated vs Bare Metal Stents in Patients Requiring Oral Anticoagulation. A Prespecified Subgroup Analysis of the LEADERS FREE Trial

Presenter: Neal S. Kleiman, David F. Kong, Didier Carrié

October 31, 2016

Presentation TCT 2016

TCT 50: Impact of a Bifurcation Culprit Lesion in ST Elevation Myocardial Infarction: Procedural Success, Clinical Outcome, and Five-Year Follow-up

Presenter: Michael J. Cowley, Franz-Josef Neumann, Pablo Salinas

October 31, 2016

Presentation TCT 2016

GRACIA-4 (and Pooled Analysis): A Prospective, Randomized Trial of Percutaneous Coronary Intervention in Patients with STEMI with and without Preceding Fibrinolytic Therapy

Presenter: Thomas F. Luscher, Patrick W. Serruys, Francisco Fdez-Aviles

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents IV: Nile

Presenter: Chaim S. Lotan, Giora Weisz, Ivo Petrov

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents III: Bioss

Presenter: Chaim S. Lotan, Giora Weisz, Robert J. Gil

October 31, 2016

Presentation TCT 2016

Egypt Presents: A Case of a High-Risk STEMI Intervention: How Did I Treat?

Presenter: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari

October 31, 2016

Presentation TCT 2016

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

Presenter: Thomas F. Luscher, Patrick W. Serruys, Alaide Chieffo

October 31, 2016

Presentation TCT 2016

TCT 93: Near-Infrared Spectroscopy-Derived Lipid Core Burden Index Predicts Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease During 4.3 Year Follow-up

Presenter: Farouc Jaffer, Amir Lerman, Eric Boersma

October 31, 2016

Presentation TCT 2016

TCT 53: Thromboembolic Event Rate Is Elevated With Lower Adherence to Warfarin and NOACs

Presenter: Neal S. Kleiman, David F. Kong, Jeffrey R Winterfield

October 31, 2016

Presentation TCT 2016

TCT 69: A Randomized Comparison of the Second Generation Biodegradable Polymer Sirolimus-Eluting Stent (EXCEL-II) and the First Generation EXCEL-I Stent in Patients With De Novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

Presenter: Giuseppe De Luca, Christoph A. Kaiser, Li Zhi

October 31, 2016

Advertisement

Acute MI/SVGS/Thrombus Containing Lesions: Mesh-Covered Mguard Prime

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

A Prospective, Randomized Trial of Impella vs Intra-aortic Balloon Counterpulsation in Patients with Cardiogenic Shock

Small Vessels: Svelte Stent On A Wire

Colombia Presents : A Case of Aorto-Cameral Fistula Management: How Did I Treat?

TCT 94: Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study

TCT 70: Final 5 Year Results from the COMPARE II Trial: Comparison Between the Durable Polymer Coated Everolimus-Eluting Xience/Promus Stent and the Biodegradable Polymer Coated Biolimus-Eluting Nobori Stent in All-Comer Population

TCT 65: Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A Pooled Patient Level Analysis From 17 Randomized Trials

TCT 62: Outcomes of Reattempt Percutaneous Coronary Intervention for Chronic Total Occlusion: Two-year Data From Retrograde Summit Registry

TCT 58: Long-term Clinical Outcomes of Patients Treated With Everolimus-Eluting Bioresorbable Scaffolds During Daily Practice Two-Year Results From the ISAR-ABSORB Registry

TCT 54: LEADERS FREE OAC: Biolimus A9 Coated vs Bare Metal Stents in Patients Requiring Oral Anticoagulation. A Prespecified Subgroup Analysis of the LEADERS FREE Trial

TCT 50: Impact of a Bifurcation Culprit Lesion in ST Elevation Myocardial Infarction: Procedural Success, Clinical Outcome, and Five-Year Follow-up

GRACIA-4 (and Pooled Analysis): A Prospective, Randomized Trial of Percutaneous Coronary Intervention in Patients with STEMI with and without Preceding Fibrinolytic Therapy

Bifurcation/Left Main Stents IV: Nile

Bifurcation/Left Main Stents III: Bioss

Egypt Presents: A Case of a High-Risk STEMI Intervention: How Did I Treat?

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

TCT 93: Near-Infrared Spectroscopy-Derived Lipid Core Burden Index Predicts Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease During 4.3 Year Follow-up

TCT 53: Thromboembolic Event Rate Is Elevated With Lower Adherence to Warfarin and NOACs

TCT 69: A Randomized Comparison of the Second Generation Biodegradable Polymer Sirolimus-Eluting Stent (EXCEL-II) and the First Generation EXCEL-I Stent in Patients With De Novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content